| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,597 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,596 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,071 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,375 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,033 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
608 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7393523 |
Peptides for active anti-cytokine immunization |
Jul. 1, 2008 |
| 7390788 |
Peptide pharmaceutical compositions |
Jun. 24, 2008 |
| 7390785 |
.tau.-conotoxin peptides |
Jun. 24, 2008 |
| 7390784 |
Administering bifunctional molecules containing a drug moiety and presenter protein ligand for therapy |
Jun. 24, 2008 |
| 7390783 |
Charged phospholipid compositions and methods for their use |
Jun. 24, 2008 |
| 7390782 |
Methods and products related to metabolic interactions in disease |
Jun. 24, 2008 |
| 7390781 |
Methods of using truncated glial cell line-derived neurotrophic factor |
Jun. 24, 2008 |
| 7390629 |
Tumor-activated prodrug compounds and treatment |
Jun. 24, 2008 |
| 7390526 |
Methods and materials for nanocrystalline surface coatings and attachment of peptide amphiphile nanofibers thereon |
Jun. 24, 2008 |
| 7390497 |
Poly(ester amide) filler blends for modulation of coating properties |
Jun. 24, 2008 |
| 7390496 |
Therapeutic treatments for repetitive hand washing |
Jun. 24, 2008 |
| 7390492 |
Vaccine to control equine protozoal myeloencephalitis in horses |
Jun. 24, 2008 |
| 7388032 |
Sustained release compositions, process for producing the same and utilization thereof |
Jun. 17, 2008 |
| 7387995 |
Method for attaching two surfaces to each other using a bioadhesive polyphenolic protein and periodate ions |
Jun. 17, 2008 |
| 7387994 |
Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent |
Jun. 17, 2008 |
| 7387993 |
Mannan-binding lectin (MBL) treatment of infections in individuals treated with TNF-.alpha.inhibitors |
Jun. 17, 2008 |
| 7387798 |
Method and composition for resuscitation |
Jun. 17, 2008 |
| 7387778 |
Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
Jun. 17, 2008 |
| 7387771 |
Method for producing an injectable medicament preparation |
Jun. 17, 2008 |
| 7387614 |
Drug delivery to the inner ear and methods of using same |
Jun. 17, 2008 |
| 7387271 |
Immunostimulatory combinations |
Jun. 17, 2008 |
| 7384917 |
Chimeric natriuretic peptides |
Jun. 10, 2008 |
| 7384916 |
Methods and compositions for preventing and treating aging or photodamaged skin |
Jun. 10, 2008 |
| 7384913 |
PT32 sperm protein, sperm c-Yes, oocyte cytoplasmic c-Yes, and uses thereof |
Jun. 10, 2008 |
| 7384912 |
Treatment of bone disorders with skeletal anabolic drugs |
Jun. 10, 2008 |
| 7384911 |
Peptides having antimicrobial properties and compositions containing them, notably for the preservation of foodstuffs |
Jun. 10, 2008 |
| 7384910 |
Small peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
Jun. 10, 2008 |
| 7384909 |
Anti-viral treatment methods using phosphatidylethanolamine-binding peptides linked to anti-viral agents |
Jun. 10, 2008 |
| 7384908 |
Orally active peptides that prevent cell damage and death |
Jun. 10, 2008 |
| 7384756 |
Methods for treating muscle diseases and disorders |
Jun. 10, 2008 |
| 7384652 |
Complexed-acidic-phospholipid-collagen composites for bone induction |
Jun. 10, 2008 |
| 7384645 |
Outer membrane vesicles from gram negative bacteria and use as a vaccine |
Jun. 10, 2008 |
| 7381705 |
Inhibitors of hepatitis C virus |
Jun. 3, 2008 |
| 7381704 |
Methods for use of short bioactive peptides |
Jun. 3, 2008 |
| 7381702 |
Methods of treating diabetes mellitus |
Jun. 3, 2008 |
| 7381701 |
Compositions and methods for treating conditions related to ephrin signaling with cupredoxins |
Jun. 3, 2008 |
| 7381700 |
Methods for treating pain associated with arthritis |
Jun. 3, 2008 |
| 7381699 |
Reagents and methods for smooth muscle therapies |
Jun. 3, 2008 |
| 7381698 |
Methods for treatment of acute pancreatitis |
Jun. 3, 2008 |
| 7381563 |
Use of cytokines and mitogens to inhibit graft versus host disease |
Jun. 3, 2008 |
| 7381416 |
Selenohydroxy acids and their derivatives, applications in nutrition, cosmetics and pharmaceutics |
Jun. 3, 2008 |
| 7381413 |
Methods and products related to metabolic interactions in disease |
Jun. 3, 2008 |
| 7378397 |
TRH-degrading ectoenzyme inhibitors |
May. 27, 2008 |
| 7378392 |
Bone and cartilage inductive proteins |
May. 27, 2008 |
| 7378389 |
Botulinum toxin neurotoxic component for treating juvenile cerebral palsy |
May. 27, 2008 |
| 7378388 |
Method of utilizing neurotrophins to manipulate reproductive capacity |
May. 27, 2008 |
| 7378387 |
Method of suppressing immune response by reducing intracellular content of glutathione in macrophages and monocytes |
May. 27, 2008 |
| 7378386 |
Anti-viral treatment methods using phosphatidylethanolamine-binding peptide derivatives |
May. 27, 2008 |
| 7378385 |
Role for GLP-1 to mediate responses to disparate stressors |
May. 27, 2008 |
| 7378384 |
WT1 substitution peptides |
May. 27, 2008 |
|
|
|
